Bellevue Life Sciences Stock Beta
| BLAC Stock | 11.30 0.04 0.36% |
Bellevue Life Sciences fundamentals help investors to digest information that contributes to Bellevue Life's financial success or failures. It also enables traders to predict the movement of Bellevue Stock. The fundamental analysis module provides a way to measure Bellevue Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bellevue Life stock.
Bellevue | Beta |
Bellevue Life Sciences Company Beta Analysis
Bellevue Life's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Bellevue Beta Driver Correlations
Understanding the fundamental principles of building solid financial models for Bellevue Life is extremely important. It helps to project a fair market value of Bellevue Stock properly, considering its historical fundamentals such as Beta. Since Bellevue Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bellevue Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bellevue Life's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Bellevue Life Sciences has a Beta of 0.0. This is 100.0% lower than that of the Capital Markets sector and about the same as Financials (which currently averages 0.0) industry. The beta for all United States stocks is 100.0% lower than that of the firm.
Bellevue Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bellevue Life's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bellevue Life could also be used in its relative valuation, which is a method of valuing Bellevue Life by comparing valuation metrics of similar companies.Bellevue Life is currently under evaluation in beta category among its peers.
Bellevue Life ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Bellevue Life's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Bellevue Life's managers, analysts, and investors.Environmental | Governance | Social |
Bellevue Fundamentals
| Return On Asset | -0.0298 | ||||
| Current Valuation | 48.64 M | ||||
| Shares Outstanding | 4.04 M | ||||
| Shares Owned By Insiders | 50.49 % | ||||
| Shares Owned By Institutions | 42.94 % | ||||
| Number Of Shares Shorted | 766 | ||||
| Price To Book | 3.14 X | ||||
| EBITDA | 944.59 K | ||||
| Net Income | 403.78 K | ||||
| Total Debt | 4.11 M | ||||
| Book Value Per Share | (0.69) X | ||||
| Cash Flow From Operations | (818.77 K) | ||||
| Short Ratio | 0.04 X | ||||
| Earnings Per Share | (0.09) X | ||||
| Market Capitalization | 45.75 M | ||||
| Total Asset | 36.63 M | ||||
| Retained Earnings | (3.91 M) | ||||
| Working Capital | (2.02 M) | ||||
| Net Asset | 36.63 M |
About Bellevue Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bellevue Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bellevue Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bellevue Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bellevue Life Sciences is a strong investment it is important to analyze Bellevue Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bellevue Life's future performance. For an informed investment choice regarding Bellevue Stock, refer to the following important reports:Check out Bellevue Life Piotroski F Score and Bellevue Life Altman Z Score analysis. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bellevue Life. If investors know Bellevue will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bellevue Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.09) | Return On Assets (0.03) |
The market value of Bellevue Life Sciences is measured differently than its book value, which is the value of Bellevue that is recorded on the company's balance sheet. Investors also form their own opinion of Bellevue Life's value that differs from its market value or its book value, called intrinsic value, which is Bellevue Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bellevue Life's market value can be influenced by many factors that don't directly affect Bellevue Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bellevue Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bellevue Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bellevue Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.